THIS DISTRIBUTION PARTNERSHIP WILL ALLOW SCIENTISTS IN AUSTRALIA TO ADOPT THE GROUND- BREAKING TELL-SEQ™ WHOLE GENOME SEQUENCING TECHNOLOGY FOR THEIR COMPLEX DNA SEQUENCING PROJECTS
September, 2020 – Universal Sequencing Technology Corporation (‘UST’), a developer of Next Generation Sequencing (NGS) technologies, today is proud to announce a commercial relationship with Golden Gateway Partners, LLC for the exclusive distribution in Australia of the game changing TELL-Seq WGS Library Prep Kit.
The TELL-Seq kit is the linked-read alternative to long-read DNA sequencing. Customers in North America, Europe, Asia, and Australia are currently using the kit to turn their short-read DNA sequencers into long-read sequencers. The kit can be used with very low input amounts of DNA for de novo DNA sequencing applications as well as elucidating genomic structural variations and genome phasing.
Universal Sequencing Technology was founded by next generation DNA sequencing veterans from Roche/454. The TELL-Seq WGS Library Preparation kit is the first product launched from UST with multiple products in the pipeline. The underlying technology behind the TELL-Seq, which stands for Transposase Enzyme Linked Long-read Sequencing, was invented by Chief Science Officer Zhoutao “Tom” Chen.
Golden Gateway Partners are experienced in assisting startup life science tools companies to grow commercially in the Asia Pacific region. With a unique business model that enables a single distribution channel across the entire Asia Pacific region combined with UST’s breakthrough technology, it created an ideal opportunity to develop a partnership.
“We are delighted to be working with Golden Gateway Partners,” stated Dr. Andrew Bond, Universal Sequencing’s Head of Commercial Strategy. “They know the genomics and sequencing market in Asia and Australia, and we know TELL-Seq will be a great fit for many researchers in Australia”.
“Our mission is to bring new and innovative technologies to emerging markets throughout Asia”, explained Matthew Levy, Managing Director at Golden Gateway Partners. “By using the chemistry developed by UST, researchers can now get much more from their investment in NGS instruments”.